An Economic Model to Compare Linezolid, Vancomycin, and Teicoplanin for the Treatment of Confirmed Methicillin-Resistant Staphylococcus Aureus Nosocomial Pneumonia In Brazil
Abstract
Authors
M.S. Niederman D. Patel J.Z. Li C Charbonneau C.N. Ferreira L. Figueiredo J.M. Stephens S. Haider